Xilin Wan

机构：Beihua University, Buchang Pharma (China), Changchun University of Chinese Medicine · ORCID：0000-0002-3905-065X

发表论文 21 篇 · 总被引 285 次 · h-index 8

代表论文

• Structural characterisation and antitumor activity against non-small cell lung cancer of polysaccharides from Sanghuangporus vaninii (2021 · Carbohydrate Polymers · 被引 96)
• Characterization of a polysaccharide from Sanghuangporus vaninii and its antitumor regulation via activation of the p53 signaling pathway in breast cancer MCF-7 cells (2020 · International Journal of Biological Macromolecules · 被引 71)
• Down-Regulation of Neogenin Accelerated Glioma Progression through Promoter Methylation and Its Overexpression in SHG-44 Induced Apoptosis (2012 · PLoS ONE · 被引 27)
• Polysaccharides of Floccularia luteovirens Alleviate Oxidative Damage and Inflammatory Parameters of Diabetic Nephropathy in db/db Mice (2023 · Frontiers in Bioscience-Landmark · 被引 19)
• Ginsenoside Rd reduces cell proliferation of non-small cell lung cancer cells by p53-mitochondrial apoptotic pathway (2024 · Heliyon · 被引 13)
• Ginsenoside Rb1 Inhibits the Proliferation of Lung Cancer Cells by Inducing theMitochondrial-mediated Apoptosis Pathway (2024 · Anti-Cancer Agents in Medicinal Chemistry · 被引 13)